90R1732 LHC-D
 
  By: Plesa H.B. No. 330
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the medical use of low-THC cannabis by patients with a
  medical condition that causes menstrual cramps.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 169.003(a), Occupations Code, is amended
  to read as follows:
         (a)  A physician described by Section 169.002 may prescribe
  low-THC cannabis to a patient if:
               (1)  the patient is a permanent resident of the state;
               (2)  the physician complies with the registration
  requirements of Section 169.004; and
               (3)  the physician certifies to the department that:
                     (A)  the patient is diagnosed with:
                           (i)  epilepsy;
                           (ii)  a seizure disorder;
                           (iii)  multiple sclerosis;
                           (iv)  spasticity;
                           (v)  amyotrophic lateral sclerosis;
                           (vi)  autism;
                           (vii)  cancer;
                           (viii)  an incurable neurodegenerative
  disease;
                           (ix)  post-traumatic stress disorder;
                           (x)  a condition that causes chronic pain;
                           (xi)  traumatic brain injury;
                           (xii)  Crohn's disease or other inflammatory
  bowel disease;
                           (xiii)  a terminal illness or a condition
  for which a patient is receiving hospice or palliative care; [or]
                           (xiv)  a condition that causes menstrual
  cramps, including premenstrual dysphoric disorder or dysmenorrhea;
  or
                           (xv)  a medical condition that is approved
  for a research program under Subchapter F, Chapter 487, Health and
  Safety Code, and for which the patient is receiving treatment under
  that program; and
                     (B)  the physician determines the risk of the
  medical use of low-THC cannabis by the patient is reasonable in
  light of the potential benefit for the patient.
         SECTION 2.  This Act takes effect September 1, 2027.